http://purl.uniprot.org/citations/26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/26908448 | http://www.w3.org/2000/01/rdf-schema#comment | "Annexin A11 (Anxa11) is associated with various cancers. Using a pair of syngeneic murine hepatocarcinoma cells, Hca-P with ~25% and Hca-F with ~75% lymph node metastatic (LNM) potentials, we demonstrated Anxa11 involvement in hepatocarcinoma lymphatic metastasis. Here, ANXA11 acted as a suppressor for the tumorigenicity, LNM and 5-FU resistance of Hca-P via c-Jun. We constructed monoclonal Hca-P cell line with stable ANXA11 knockdown. Although Bax and Bcl-2 levels increased in shRNA-Anxa11-transfected Hca-P, ANXA11 downregulation showed no clear effect on Hca-P apoptosis. ANXA11 downregulation promoted in vitro migration and invasion capacities of Hca-P. In situ adhesion potential of Hca-P cells toward LN was significantly enhanced following ANXA11 downregulation. Consistently, ANXA11 downregulation promoted the in vivo tumor growth and LNM capacities of Hca-P cells. ANXA11 knockdown enhanced the chemoresistance of Hca-P cells specifically toward 5-FU instead of cisplatin. Its downregulation increased c-Jun (pSer73) and decreased c-Jun (pSer243) levels in Hca-P. c-Jun (pSer243) downregulation seemed to be only correlated with ANXA11 knockdown without the connection to 5-FU treatment. Interestingly, compared with scramble-Hca-P cells, the levels of c-Jun and c-Jun (pSer73) in shRNA-Anxa11-Hca-P cells were upregulated in the presences of 0.1 and 1.0 mg/L 5-FU. The levels changes from c-Jun and c-Jun (pSer73) in Hca-P cells showed a more obvious tendency with the combination of ANXA11 knockdown and 5-FU treatment. ANXA11 level regulates LNM and 5-FU resistance of Hca-P via c-Jun pathway. It might play an important role in hepatocarcinoma cell malignancy and be a therapeutic target for hepatocarcinoma."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.org/dc/terms/identifier | "doi:10.18632/oncotarget.7484"xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/author | "Liu S."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/author | "Qi H."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/author | "Guo C."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/author | "Wang J."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/author | "Wang B."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/author | "Sun M.Z."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/date | "2016"xsd:gYear |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/name | "Oncotarget"xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/pages | "16297-16310"xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/title | "ANXA11 regulates the tumorigenesis, lymph node metastasis and 5-fluorouracil sensitivity of murine hepatocarcinoma Hca-P cells by targeting c-Jun."xsd:string |
http://purl.uniprot.org/citations/26908448 | http://purl.uniprot.org/core/volume | "7"xsd:string |
http://purl.uniprot.org/citations/26908448 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/26908448 |
http://purl.uniprot.org/citations/26908448 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/26908448 |
http://purl.uniprot.org/uniprot/#_Q52L79-mappedCitation-26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/#_Q3V255-mappedCitation-26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/#_P05627-mappedCitation-26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/#_P97384-mappedCitation-26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/#_Q3US19-mappedCitation-26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/#_Q6TDG5-mappedCitation-26908448 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/P97384 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/P05627 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/26908448 |
http://purl.uniprot.org/uniprot/Q52L79 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/26908448 |